Lassen
Overview
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
Funding and backers
Total raised
$85M
1 round on record
Latest round
$85M
Venture round · Dec 2023 · 2 yr ago
Backers
2
Alta Partners, Longitude Capital
The money's age
Long since its last round
34 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 21, 2023
Raised a round Venture round $85M · Pulse 2.0
Jun 16, 2020
Launched Lassen Therapeutics Launches to Discover and Develop Novel Antibody Therapeutics Including Lead Program Targeting IL-11 to Treat Fibrosis and Oncology · businesswire.com
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2023 | $85M | — | Pulse 2.0 |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Advancing medicines to restore homeostasis. Cajal Therapeutics is developing novel medicines for serious diseases, including anemias of…
Innovative therapeutics that target serious viral and liver diseases Assembly Bio is applying our passion, scientific ingenuity and deep…
SymPhysis Medical specializes in medical technology designed to improve the lives of patients with chronic conditions.
It's time to think again about therapies for psychiatric and neurodegenerative disease. At CuraSen, we are targeting these brain diseases…
AltruBio. Developing safer, more durable treatments to improve the lives of patients.
Neuron23 is developing a precision medicine approach designed to improve the lives of people with Parkinson’s disease.
Financials
Total raised
$85M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2023 | $85M | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Alta PartnersVia a fund
Longitude CapitalVia a fund
78 portfolio companies: Zenas BioPharma, Mobia Medical, Inc. and 76 more
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Lassen Peak Awarded Two Foundational Patents for World
/PRNewswire/ -- Following a multi-year development effort, Lassen Peak, Inc. announced today the award of two U.S. patents for its AirFrisk handheld concealed...
Read more
Report
Lassen Volcanic National Park: California's spectacular alternative to Yosemite
Yosemite may get all the attention, but a road trip to Lassen's otherworldly landscape offers a hit of jaw-dropping natural beauty - without the crowds.
Read more
Report
Lassen Therapeutics: $85 Million Raised To Develop Fibro-Inflammatory Disease Treatments
Lassen Therapeutics - a clinical-stage biotech company developing first-in-class antibody therapeutics LASN01 targeting interleukin-11 receptor (IL-11R) as a potential treatment for fibro-inflammatory diseases like TED and IPF, and a highly potent, first-
Read more
Report
Lassen Therapeutics Announces Presentations on Novel IL-11 Receptor-Blocking Antibody at the American Thoracic Society 2022 Annual Meeting
Read more
Report
Nancy Faeser will Telegram aus den App-Stores werfen lassen
Apple und Google sollen ihrer gesellschaftlichen Verantwortung nachkommen: Bundesinnenministerin Faeser will die beiden US-Konzerne auffordern, Telegram aus ihren App-Stores zu verbannen.
Read more
Report
Report
Lassen Therapeutics Launches to Discover and Develop Novel Antibody Therapeutics Including Lead Program Targeting IL-11 to Treat Fibrosis and Oncology
Read more
Report
Lassen Is UC Davis' Newest Natural Reserve
With a terrain covering volcanoes, steaming fumaroles and forestlands, the Lassen Field Station became the newest addition to the University of California, Davis' Natural Reserve System today (May 16), following approval by the UC Board of Regents.
Read more
Report
Show more news